These immunotherapy approaches may indirectly upregulate IFN-inducible NAMPT in tumors cells, and we hypothesize that their efficacy can be enhanced by combining these therapies with NAMPT inhibitors that specifically target tumor cells. Here, NAMPT is linked to neoplasm.